About Clay

After graduating from Notre Dame Law School, Clay has spent the vast majority of his 15 year legal career representing mesothelioma victims and their families.

Since 2015, Clay has been the partner in-charge of MRHFM’s New York City, New Jersey and Philadelphia offices.

Clay has appeared before juries on behalf of Firm clients across the country, including New York, New Jersey, Pennsylvania, Louisiana, Washington and West Virginia. Clay has lead trial teams on behalf of clients exposed to asbestos at chemical plants, in truck garages, and from laundering their family member’s asbestos-laden clothing.

Clay and other Firm partners Christian Hartley and Marcus Raichle obtained a verdict from a Philadelphia jury for a former Ford dealership employee in 2011. Clay and the Firm represented this client through several appellate stages until the verdict was upheld by the Pennsylvania Supreme Court in 2016.

In 2014, Clay represented a former boilermaker in a New York City trial that resulted in a $7 million dollar jury verdict.

During his time with the Firm, Clay and his team have obtained seven figure total settlements for clients with varied exposure, including from power plants, oil refineries, automotive garages, and from the use of asbestos-talc products.

Clay has recently been heavily involved in representing mesothelioma victims against attempts by Johnson & Johnson and other large profitable companies to abuse the bankruptcy system and deprive mesothelioma victims from having their cases heard by a jury.


  • University of Notre Dame Law School
    Notre Dame, IN
  • University of Illinois - Chicago
    Chicago, IL

Practice Area

  • Mesothelioma


Clay is licensed in Pennsylvania, New York, New Jersey, Illinois, and Missouri, and serves clients throughout the United States.

Contact Us

If you have been diagnosed with mesothelioma and would like to learn more about your legal rights to mesothelioma compensation, please complete the form below for a free consultation.

  • Who has Mesothelioma?
  • Has there been a biopsy?
  • What is your current treatment plan?
  • Text Message Opt-in